12-Step ProgramsSubstance Use Disorder treatment programs often involving twelve steps
toward becoming spiritually enlightened and as a result, sober. The two
most popular associations are Alcoholics Anonymous (AA) and Narcotics
Anonymous (NA). |
AAPPQShort Alcohol and Alcohol Problems Perception Questionnaire. |
AbstinenceThe cessation of all consumption of a particular substance or a variety
of substances. Often the ultimate goal of substance dependence
treatments. |
Abuse of a SubstanceMaladaptive pattern of use leading to clinically significant impairment
manifesting one or more of the following within a 12-month period:
behavioral impairment, use in hazardous situations, legal problems,
recurrent use in spite of social and interpersonal problems. |
AcamprosateA prescription drug used to treat alcohol dependence by interacting with the glutamate neurotransmitter system. |
Alcohol withdrawalBegins within 6 hours of the last drink and can range from minor
withdrawal (insomnia, tremulousness, anxiety, GI upset) to seizures,
hallucinations and at its most severe, delirium tremens. |
ASSISTAlcohol, Smoking, and Substance Involvement Screening Test — an
instrument developed for the World Health Organization (WHO) by an
international group of substance abuse researchers to detect and manage
substance use and related problems in primary and general medical care
settings. |
AUDITAlcohol Use Disorders Identification Test — a screening tool developed
by the World Health Organization to identify persons whose alcohol
consumption has become hazardous or harmful to their health. It is a
10-item screening questionnaire with 3 questions on the amount and
frequency of drinking, 3 questions on alcohol dependence, and 4 on
problems caused by alcohol. All of the questions are scored using a
5-point Likert scale. |
Brief InterventionBrief dialogues with patients exploring the consequences of substance
use with the intent to strengthen the patient’s own motivation and
commitment to positive behavior change. |
Buprenorphine |
Buproprion |
CAGEA brief alcoholism screening tool that inquires about a patient's
attempts to Cut down on drinking, Annoyance over others' criticism of
the patient's drinking, Guilt related to drinking, and use of an
alcoholic drink as an Eye opener. |
CDCCenters for Disease Control and Prevention (federal level). |
ConfidentialityExtra precautions are taken for the confidentiality of SUD. Information
regarding Substance Abuse Problems is confidential and cannot be
released to another provider without the specific signed release of
information from the patient or a subpoena. This legislation is defined
by the Federal Regulation "Confidentiality of Alcohol and Drug Abuse
Patient Records.” |
CRAFFT |
DASTDrug Abuse Screening Test — A brief instrument used to detect drug abuse
or dependence disorders. The DAST provides a general measure of
lifetime problem severity that can be used to guide further inquiry into
drug-related problems and to help determine treatment intensity. |
DDAPDepartment of Drug and Alcohol Programs (state level: PA). |
DDPPQDrug and Drug Problems Perception Questionnaire. |
Delirium tremensAn alcohol withdrawal syndrome characterized by hallucinations,
disorientation, tachycardia, hypertension, low grade fever, agitation
and diaphoresis. It occurs in 5% of patients experiencing withdrawal,
typically begins between 48 and 72 hours after the last drink, can last
one to five days and has a mortality rate of 5% (death is usually due to
arrhythmias or complicating illnesses such as pneumonia). |
Dependence on a substanceMaladaptive pattern of use leading to clinically significant impairment
manifesting three or more of the following within a 12-month period:
tolerance, withdrawal, using more than intended, preoccupation with use,
narrowing of non-drug use activities, continued use in spite of
negative consequences, compulsive use. |
Dextromethorphan Hydrobromide |
DisulfiramA prescription medication that causes illness when the patient consumes
alcohol. Used for alcohol cessation. Sold under the brand name Antabuse. |
DSMThe Diagnostic and Statistical Manual of Mental Disorders, published by
the American Psychiatric Association. The current version is the DSM-V. |
ETOHEthanol (the type of alcohol most commonly used for human consumption). |
Faculty Champion"Those faculty members with passion for new ideas, who can lead and
teach others and who are willing to put the energy into both learning
and driving a process of (innovative practice) implementation" (Mengal,
Pauwels, and Frey, 2007, p. 284). |
FDAFood and Drug Administration (federal level). |
FLO(Part of motivational interviewing) Feedback, Listening, Options for Change. |
Follow-upAny inquiry occurring at some defined/discrete point following a
posttest. The inquiry may be a formal or informal assessment or
evaluation of some phenomenon, usually but not always related to the
pretest and posttest. Follow-up assessment may occur at any time point
after the posttest (for example, 30 days, 60 days, 1 year, etc.). |
GPRAThe Government Performance and Results Act of 1993. Legislation enacted
in order to monitor and assess the performance and outcomes of all
Federal agencies. Also used to describe the instruments and
questionnaires required for all Federally-funded grants and projects. |
HallucinogenA broad group of drugs that cause distortions of sensory perception. The
prototype hallucinogen is lysergic acid diethylamide (LSD). LSD can
cause potent sensory perceptions, such as visual, auditory, and tactile
hallucinations. Related hallucinogens include peyote and mescaline. |
Hazardous Alcohol ConsumptionA pattern or quantity of alcohol use which places the person at
increased risk for alcohol related harm.This is defined by the WHO as
more than 4 drinks in a day or more than 14 drinks per week for men
under 65, or more than 3 drinks in a day or more than 7 drinks in a week
for all women and for men over 65. |
Inpatient treatmentIncludes the following types of treatment: medically monitored inpatient
detox, medically managed inpatient detox, medically managed inpatient
residential. |
M-ASTA screening test for alcohol use, related to the DAST for drug use. Michigan Alcohol Screening Test. |
M.I. |
Medial forebrain bundle (Mesolimbic dopamine system)“Pleasure pathway” of the brain involved with substance dependence. |
Methodone |
Motivational InterviewingA style of patient-led discussion intended to change behaviors.
Important concepts include partnership (dancing not wrestling),
acceptance (respect, empathy, autonomy, affirmation), compassion and
evocation. |
NaloxoneAn opioid antagonist used most commonly to reverse opioid overdoses.
Causes immediate overdose reversal and opioid withdrawal. Sold under the
brand name Narcan. |
NaltrexoneAn FDA-approved medication to reduce treat alcohol dependence and opiate
addiction by reducing cravings and “reward” from substance use. Sold as
ReVia and Vivitrol. |
NicotineThe addictive component in tobacco products. |
OpiateThe non-synthetic derivatives derived from the poppy plant. |
OpioidSemi-synthetic (partially derived from the plant) and synthetic drugs
(not derived from the plant) which mimic opiate actions. A type of
depressant drug that diminishes pain and central nervous system
activity. Prescription opioids include morphine, meperidine (Demerol),
methadone, codeine, and various opioid drugs for coughing and pain.
Illicit opioids include heroin. |
Outpatient treatmentIncludes the following types of treatment: partial hospitalization, intensive outpatient, early intervention (education). |
PCPPrimary Care Physician. |
PCPCPennsylvania’s Client Placement Criteria for Adults. A methodology for
determining level of treatment and a placement tool for insurers. |
Posttest |
PretestAny inquiry occurring prior to exposure to an intervention or
experience. Inquiries may include formal or informal assessments or
evaluations (tests, quizzes, surveys) of some phenomenon. Also known as a
"baseline assessment". Pretests are often used in conjunction with
posttests. |
Referral to TreatmentActively assisting patients with appropriate treatment and linkages to
recovery support for patients who require more extensive treatment and
access to specialty care. |
SAMHSASubstance Abuse and Mental Health Services Administration (federal level). Pronounced "SAM-suh." |
SBIRT |
SCASingle County Authority for Drug and Alcohol. SCAs plan, coordinate,
programmatically and fiscally manage and implement the delivery of drug
and alcohol prevention, intervention, and treatment services at the
local level. |
ScreeningA formal process of assessment to determine whether a patient warrants
further attention at the current time for a particular disorder. |
Standard DrinkIn the United States, one standard drink contains 14 grams of alcohol.
Equivalent to 12 fl oz of beer (5% alcohol by volume), 8-9 fl oz of malt
liquor or imported/specialty beers (7% ABV), 5 fl oz of table wine (12%
ABV), 3-4 fl oz of fortified wine such as sherry or port (17% ABV), 2-3
fl oz of cordial, liqueur or aperitif (24% ABV) or 1.5 oz (one shot or
jigger) of 80-proof spirits (40% ABV). |
StimulantA class of drugs that have a stimulating or excitatory effect on the
central nervous system. common stimulants include cocaine, caffeine, and
amphetamines. |
SuboxoneA substance used to treat opioid addiction. A combination of
buprenorphine (agonist) and naloxone (antagonist) with a minimal abuse
potential. Unlike methodone, can be prescribed in an office environment. |
SUDSubstance Use Disorder. |
Varenicline |
WHOWorld Health Organization (international level). |